EN
HI
Alembic Pharmaceuticals share price chart
Alembic Pharmaceuticals Share Key Metrics
Volume
1.43 L
Market Cap
16190.90 CR
LTQ@LTP
4@823.70
ATP
817.99
Var Margin
16.2 %
Circuit Range
654.65-981.95
Delivery %
32.82 %
Value
11.71 CR
ASM/GSM
No
Market Lot
1
Summary
APLLTD stock price is ₹823.7 as of 5 Jul, 2026. The stock intraday movement has stayed between ₹809.50 and ₹834.15, while Alembic Pharmaceuticals share price 52 week high low is ₹635.80 & ₹1107.90.
In terms of trading activity, APLLTD share price has recorded a volume of 1,43,213 shares. The Alembic Pharmaceuticals has a market cap of ₹196563124. The stock’s Average Traded Price (ATP) stands at ₹817.99, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 4 @ ₹823.70.
The Alembic Pharmaceuticals upper circuit limit is ₹981.95 & The Alembic Pharmaceuticals lower circuit limit is ₹654.65, with a Value of ₹11.71 CR. The Delivery Percentage for the day is 32.82%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Alembic Pharmaceuticals Fundamentals
P/E Ratio
23.96
P/B Ratio
2.85
Div. Yield
1.46
Sector P/E
70.4
Sector P/B
3.22
Sec. Div. Yield
0.53
Alembic Pharmaceuticals Resistance and Support
Pivot 822.4
Resistance
First Resistance
835.9
Second Resistance
853.5
Third Resistance
867
Support
First Support
804.8
Second Support
791.3
Third Support
773.7
Alembic Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-15 | Audited Results & Final Dividend |
| 2026-02-05 | Quarterly Results |
| 2025-11-04 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results & Others |
Alembic Pharmaceuticals News
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Credit Rating
CRISIL Ratings has reaffirmed Alembic Pharmaceuticals' AA+/Stable rating for long-term bank facilities and A1+ for commercial paper. The bank facility limits have been enhanced from Rs. 800 crore to Rs. 1,100 crore.
Jul 01 2026 18:43:57
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Alembic Pharmaceuticals received USFDA final approval for its Abbreviated New Drug Application (ANDA) for Dapsone Gel, 5%. This approval enables the company to market its drug for topical acne treatment in the US.
Jun 26 2026 19:11:05
Read More
Alembic Pharmaceuticals Management
| Name | Position |
|---|---|
| Chirayu Amin | Chairman & CEO |
| Pranav Amin | Managing Director |
Alembic Pharmaceuticals Similar Stocks
Onesource Specialty Pharma Ltd.
1669.00
-18.60 (1.10%)
Astrazeneca Pharma India Ltd.
8310.50
68.50 (0.83%)
Cohance Lifesciences Ltd.
454.50
1.90 (0.42%)
Poly Medicure Ltd.
1677.80
-54.50 (3.15%)
Natco Pharma Ltd.
931.40
-3.10 (0.33%)
Jubilant Pharmova Ltd.
969.20
-4.00 (0.41%)
Dr. Agarwal's Health Care Ltd.
477.60
1.00 (0.21%)
Rainbow Children's Medicare Ltd.
1440.00
19.20 (1.35%)
Vijaya Diagnostic Centre Ltd.
1365.20
-32.60 (2.33%)
Concord Biotech Ltd.
1274.90
-11.20 (0.87%)
Alembic Pharmaceuticals FAQs
The Buying Price of Alembic Pharmaceuticals share is 823.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alembic Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alembic Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alembic Pharmaceuticals shares is 23.96. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alembic Pharmaceuticals shares is 2.85. Useful to assess the stock's value relative to its book value.
To assess Alembic Pharmaceuticals’s valuation compare Sector P/E, P/B which are 70.4 & 3.22 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alembic Pharmaceuticals is 16190.90 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alembic Pharmaceuticals share price is 1107.90 & 635.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alembic Pharmaceuticals belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
